Article révisé par les pairs
Titre :
  • Management of metastatic HER2-positive breast cancer progression after adjuvant trastuzumab therapy - current evidence and future trends.
Auteur : Metzger-Filho, Otto ; Vora, Tushar Shailesh ; Awada, Ahmad
Informations sur la publication : Expert opinion on investigational drugs, 19 Suppl 1, (page S31-S39)
Statut de publication : Publié, 2010-04
Sujet CREF : Cancérologie
Mots-clés : Adjuvant therapy
Chemotherapy
Human epidermal growth factor receptor-2 (HER2)
Metastatic breast cancer
Trastuzumab
Tyrosine kinase inhibitors
Mots-clés MeSH : Antibodies, Monoclonal -- administration & dosage
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols -- pharmacokinetics -- therapeutic use
Breast Neoplasms -- drug therapy -- pathology
Chemotherapy, Adjuvant -- methods
Disease Progression
Drug Delivery Systems
Drug Resistance, Neoplasm
Female
Humans
Neoplasm Metastasis
Receptor, erbB-2 -- antagonists & inhibitors -- metabolism
Signal Transduction -- drug effects
Note : Journal Article
Research Support, Non-U.S. Gov't
Review
SCOPUS: cp.j
Langue :
  • Anglais
Identificateurs : urn:issn:1354-3784 
info:doi/10.1517/13543781003730135
info:pmid/20374028